文献速递心境障碍物质与行为成瘾会诊联络精神医学

针对自杀住院患者的简短认知行为治疗:一项随机临床试验

Brief Cognitive Behavioral Therapy for Suicidal Inpatients: A Randomized Clinical Trial.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

这项随机临床试验在康涅狄格州一家私立精神病医院比较了常规治疗(n=106)与常规治疗联合住院版简短认知行为治疗(n=94),随访6个月。结果显示,联合治疗使出院后6个月内自杀未遂发生风险降低60%(OR 0.40,95%CI 0.20-0.80,需治疗人数7),在无物质使用障碍者中精神病再入院率降低71%(率比0.29,95%CI 0.09-0.90);对自杀意念的影响较不明确。

要点

  • 住院版简短认知行为治疗联合常规治疗使出院后6个月自杀未遂风险降低60%(OR 0.40,95%CI 0.20-0.80,需治疗人数7)。
  • 在无物质使用障碍者中,联合治疗使精神病再入院率降低71%(率比0.29,95%CI 0.09-0.90)。
  • 对自杀意念的影响较不明确,事后分析显示出院后1个月和2个月时联合治疗组自杀意念较常规治疗组轻。

核心结论

  • 在常规治疗基础上加用住院版简短认知行为治疗,可减少出院后6个月内的自杀再未遂和再入院率,物质使用障碍调节了治疗对再入院率的影响。
  • 治疗对自杀意念的影响较不明确,需要实施研究以促进推广,也需要进一步研究以优化物质使用障碍患者的结果。

研究设计与样本

  • 这项随机临床试验在康涅狄格州一家私立精神病医院比较常规治疗(n=106)与常规治疗联合住院版简短认知行为治疗(n=94)。
  • 筛查连续入院的病历共4137份,213例符合研究条件并随机分组,最终分析200例;出院后6个月每月完成随访评估。
  • 参与者于2020年1月至2023年2月入组,均为因自杀危机入院(入院前一周有自杀未遂或自杀意念伴计划,且过去2年内有自杀未遂)的住院患者。
  • 共有114名参与者(57.0%)完成了6个月随访评估,同时获取了截至6个月随访的病历数据。

主要发现

  • 200例分析参与者的平均(标准差)年龄为32.8(12.6)岁;117名为女性,83名为男性。
  • 住院版简短认知行为治疗使全部患者出院后6个月内自杀未遂发生风险降低60%(OR 0.40,95%CI 0.20-0.80,需治疗人数7)。
  • 在无物质使用障碍者中,住院版简短认知行为治疗使精神病再入院率降低71%(率比0.29,95%CI 0.09-0.90)。
  • 治疗条件对自杀意念的影响较不明确,但事后分析显示出院后1个月和2个月时住院版简短认知行为治疗组较常规治疗组自杀意念严重程度更轻。

关键数值与推荐

  • 住院版简短认知行为治疗为最多4次个体 sessions,专为住院患者设计。
  • 自杀未遂和再入院通过盲法访谈和病历回顾评估,自杀意念通过自我报告评估。

临床怎么用

  • 作者认为,在常规治疗基础上加用住院版简短认知行为治疗可减少出院后6个月内的自杀再未遂和再入院率。
  • 作者指出需要实施研究以促进推广,并需要进一步研究以优化物质使用障碍患者的结果。

局限性

  • 治疗对自杀意念的影响较不明确。
  • 需要实施研究以促进推广。
  • 还需要进一步研究以优化物质使用障碍患者的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Suicide risk is elevated after discharge from inpatient level of care. Empirically supported inpatient suicide prevention treatments are needed. OBJECTIVE: To determine whether adding an inpatient version of brief cognitive behavioral therapy for suicide prevention to treatment as usual reduces postdischarge suicide attempts, suicidal ideation, and psychiatric readmissions and to determine whether substance use disorder moderates treatment effects. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial compared treatment as usual (n = 106) to treatment as usual plus brief cognitive behavioral therapy for inpatients (n = 94) at a private psychiatric hospital in Connecticut. Follow-up assessments were completed monthly for 6 months postdischarge. Participants were enrolled from January 2020 through February 2023. Inpatients admitted following a suicidal crisis (past-week suicide attempt or ideation with plan on admission and attempt within previous 2 years) were included. Medical records of consecutive admissions (n = 4137) were screened, 213 were study eligible and randomized, and 200 were analyzed. A total of 114 participants (57.0%) completed 6-month follow-up assessments. Data from medical records were also obtained through 6-month follow-up. INTERVENTION: Up to 4 individual sessions of brief cognitive behavioral therapy for suicide prevention designed for inpatients. MAIN OUTCOMES AND MEASURES: Suicide attempts and readmissions were assessed via blind interviews and medical record review. Suicidal ideation was assessed via self-report. RESULTS: The mean (SD) age among 200 analyzed participants was 32.8 (12.6) years; 117 participants were female and 83 were male. Brief cognitive behavioral therapy-inpatient reduced the occurrence of suicide attempt over 6 months postdischarge by 60% (odds ratio, 0.40; 95% CI, 0.20-0.80; number needed to treat, 7) in the entire patient group, and the rate of psychiatric readmissions by 71% (rate ratio, 0.29; 95% CI, 0.09-0.90) in those without a substance use disorder. The effect of treatment condition on suicidal ideation was less clear, although post hoc analyses indicated less severe suicidal ideation following brief cognitive behavioral therapy-inpatient vs treatment as usual at 1 and 2 months postdischarge. CONCLUSIONS AND RELEVANCE: Brief cognitive behavioral therapy-inpatient reduced 6-month postdischarge suicide reattempts and rate of readmissions when added to treatment as usual. Substance use disorder moderated the treatment's effect on readmission rates. Treatment effects on suicidal ideation were less clear. Implementation research is needed to facilitate dissemination. Additional research is also needed to optimize outcomes for individuals with substance use disorders. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04168645.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Diefenbach GJ, Lord KA, Stubbing J, et al. Brief Cognitive Behavioral Therapy for Suicidal Inpatients: A Randomized Clinical Trial. JAMA Psychiatry. 2024. PMID: 39259550. doi:10.1001/jamapsychiatry.2024.2349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。